This inventor holds 8 USPTO granted patents and 9 published patent applications and 1 EPO patent. Top assignee: Visterra, Inc.. Active years: 2019-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2025
Title: Hedy Adari-Hall: Innovator in Antibody Molecule Development
Introduction
Hedy Adari-Hall is a prominent inventor based in Sudbury, MA (US), known for her significant contributions to the field of biotechnology. With a total of 8 patents to her name, she has made remarkable advancements in the development of humanized antibody molecules.
Latest Patents
Among her latest patents is the development of humanized antibody molecules to CD138, which are designed to treat, prevent, and diagnose disorders such as multiple myeloma. Another notable patent involves a method of using antibody molecules to detect a proliferation-inducing ligand (APRIL), which can be utilized in the treatment and diagnosis of disorders like IgA nephropathy.
Career Highlights
Hedy Adari-Hall has established herself as a key figure in her field, working at Visterra, Inc., where she continues to innovate and push the boundaries of antibody research. Her work has the potential to significantly impact the treatment of various diseases.
Collaborations
She collaborates with talented individuals such as James R Myette and Zachary Shriver, contributing to a dynamic research environment that fosters innovation.
Conclusion
Hedy Adari-Hall's work in the development of antibody molecules showcases her dedication to advancing medical science and improving patient outcomes. Her contributions are invaluable to the field of biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile